Vestaron produces insecticides for agriculture, animal health, non-crop, and commercial pest control applications.
Vestaron produces insecticides for agriculture, animal health, non-crop, and commercial pest control applications.
Agricultural Chemicals📍 Durham, NCFounded 2005
Current Valuation
$551M
as of 2025-Q2
PRIVATE
QL Price
$551M
0% vs last round
QuantLogix's current estimate for Vestaron, published 2026-09-27 — in line with the last disclosed round of $551M (2025-Q2).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$551M
2025-Q2
weight 0.42
How this price has held up
No round has priced for Vestaron since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Vestaron, 2026-09-27 (d613bedf4f393e6b).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Vestaron going public?
No. Vestaron is private and has not filed to go public. There is no S-1 on file.
What is Vestaron's valuation in 2026?
Vestaron is valued at $551M as of 2025-Q2, set by its Later Stage VC ($102.75M, Apr 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Vestaron filed an S-1?
No public S-1 is on file for Vestaron.
How much has Vestaron raised?
Vestaron has raised $302.09M in total, most recently a Later Stage VC of $102.75M in Apr 2025.
Is Vestaron publicly traded — can you buy Vestaron stock?
No. Vestaron is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Vestaron on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2005
HQ
Durham, NC
Employees
51
Total Raised
$302.09M
Last Round
Later Stage VC — $102.75M (Apr 2025)
IPO Status
private
Fundraising Status
Later Stage VC · $102.75M · 1y 5mo ago
privateTotal raised $302.09M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Later Stage VC
$102.75M
Apr 2025
—
$551M
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for Vestaron — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-19. Re-checked weekly.
Talent Signal
No public careers page or job board could be found for Vestaron as of 2026-09-17. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
AgricultureBiotechnologyFarming
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q2. Refreshed quarterly.